Case Summary:

A postdoctoral fellow from India approached North America Immigration Law Group to file his alien of extraordinary ability (EB1-A) petition. He has completed his medical education from India and is currently employed in the field of biomedical research.

We assimilated the following essentials from his academic and professional records in his petition packet to make a persuasive case in his favor:

• His research has regularly inspired further advances in machine learning and artificial intelligence.
• His research has resulted in 25 peer-reviewed scientific articles, being cited 2010 times according to Google Scholar in at least 68 countries.
• He has completed at least 21 reviews to date.

Since, a petition for an employment-based immigration visa under the second preference (“EB-2”), unlike the first preference category of individuals with extraordinary ability, (“EB1-A”), at least requires:

• Evidence of original contributions, usually through publication, of major significance in the foreign national’s field of science, scholastic, artistic, or athletic.
• No specific job offer/labor certification is required for a foreign person as long as he/she is entering the United States to continue work in the field in which he/she has an extraordinary ability, therefore self-petition is allowed.
• Performance in a significant role for organizations or establishments that have a distinguished reputation.
• Receipt of a higher salary or remuneration than is usual in the field.
• Other comparable evidence if the above types of evidence do not readily apply to the foreign national’s occupation.

Therefore, Our client’s unique and expansive expertise has enabled him to contribute significantly to the field of biomedical research, extending the reasonable expectation that he will continue to do so within the United States.

The importance of his background and accomplishments in his area of expertise is discussed further in letters of support from four fellow experts in the field, one of whom remarked:

“[Client] has contributed significantly to his field as well as the future of healthcare globally. His academic and professional experience has allowed him to successfully complete lifesaving research. Additionally, he has also been able to further the work of his colleagues through their citations of his work and through his role in the peer-review process. Thus, it is detrimental to the United States if [client’s] research were to be interrupted. The continuation of his work is of the utmost benefit to the country.”

Eventually, he achieved his EB1-A (Alien of Extraordinary Ability) approval in just 13 days (thanks to premium processing). His NIW (National Interest Waiver) application is also under the PL stage. We are pleased to have been able to help him achieve this breakthrough and wish him the best of luck for his future.